|
1.
|
原著
|
Complete Remission After Percutaneous Renal Artery Angioplasty for Focal Segmental Glomerulosclerosis due to Takayasu Disease: A Case Report. 2026/03
|
|
2.
|
原著
|
Association of anemia with long-term renal prognosis in autosomal dominant polycystic kidney disease using time-series analysis. 2026/02/27
|
|
3.
|
原著
|
Machine learning for predicting CKD stages in patients with autosomal dominant polycystic kidney disease: a nationwide cohort study in Japan. 2026/02/13
|
|
4.
|
原著
|
Middle cerebral artery aneurysms in older women with autosomal dominant polycystic kidney disease. 2025/10/30
|
|
5.
|
原著
|
Ectopic parathyroid hormone-producing cervical cancer requiring hemodialysis owing to acute hypercalcemia: a case report 2025/10/13
|
|
6.
|
原著
|
Successful kidney transplantation after significant improvement of left ventricular function with guideline-directed medical therapy including angiotensin receptor-neprilysin inhibitor and beta blocker in a hemodialysis patient: a case report 2025/10/07
|
|
7.
|
原著
|
Anemia and Kidney Prognosis in ADPKD: Insights from Attribute-Based Cross-Classification by Sex and Age 2025/10
|
|
8.
|
原著
|
Attribute-Based Cross-Classification of ADPKD Complications: A Nationwide Cohort Study from Japan 2025/10
|
|
9.
|
原著
|
Attribute-Based Medicine for IgAN: A Nationwide Japanese Cohort Reveals Prognostic Interactions 2025/10
|
|
10.
|
原著
|
Challenges in the Histopathologic Diagnosis of Autosomal Dominant Alport Syndrome: A Comparative Genotype-Based Study 2025/10
|
|
11.
|
原著
|
Disease-Specific Prevalence and Clinical Significance of Antinephrin Autoantibodies in Adult Japanese Patients with Podocytopathy: A Single-Center Cohort Study, 2016-2024 2025/10
|
|
12.
|
原著
|
Factors Associated with Loss of Kidney Function in Patients with PKD: A Nationwide Real-World Data Analysis 2025/10
|
|
13.
|
原著
|
Granulomatous Interstitial Nephritis Suspected to Be Caused by Adverse Reaction to Metal Debris: A Case Report 2025/10
|
|
14.
|
原著
|
High-Pulse Pressure and Kidney Prognosis in ADPKD: Insights from Attribute-Based Cross-Classification by Sex and Age 2025/10
|
|
15.
|
原著
|
Hypertriglyceridemia and Kidney Prognosis in ADPKD: Insights from Attribute-Based Cross-Classification by Sex and Age 2025/10
|
|
16.
|
原著
|
Hyperuricemia and Kidney Prognosis in ADPKD: Insights from Attribute-Based Cross-Classification by Sex and Age 2025/10
|
|
17.
|
原著
|
Increased Risk of Middle Cerebral Artery Aneurysms in Postmenopausal Women with ADPKD: Insights from Attribute-Based Medicine (ABM) with Cross-Classification Based on Sex and Age 2025/10
|
|
18.
|
原著
|
Intracranial Aneurysms and Hemorrhages in ADPKD: An Attribute-Based Cross-Classification Analysis in a Nationwide Japanese Cohort 2025/10
|
|
19.
|
原著
|
Prognostic Prediction Model for CKD Stages by Machine Learning in Patients with ADPKD: A Nationwide Cohort Study in Japan 2025/10
|
|
20.
|
原著
|
腎生検所見から何を学ぶか 東京腎生検カンファランス(No.68) Adverse reaction to metal debrisによる肉芽腫性間質性腎炎が疑われる1例 2025/10
|
|
21.
|
原著
|
ATTR wildtypeアミロイドーシスに併発した分節性NELL-1陽性膜性腎症の一例 2025/09/10
|
|
22.
|
原著
|
CKD合併妊娠から周産期心筋症を呈し,遺伝子検査でミトコンドリア病と診断され末期腎不全に至った一例 2025/09/10
|
|
23.
|
原著
|
NPHP3およびNPHP4変異の二遺伝子遺伝によるネフロン癆の一例 2025/09/10
|
|
24.
|
原著
|
経時的に増大した腎腫瘤を契機に腎サルコイドーシスの診断に至った透析患者の一例 2025/09/10
|
|
25.
|
原著
|
血尿・糸球体腎炎を認めず,腎機能障害を契機に診断されたANCA関連血管炎(AVV)の2例 2025/09/10
|
|
26.
|
原著
|
高安病による腎動脈狭窄により呈したネフローゼ症候群にPTRAを施行し寛解導入となった一例 2025/09/10
|
|
27.
|
原著
|
生検後長期間経過したのち再生検となったAlport症候群の2例 2025/09/10
|
|
28.
|
原著
|
双胎妊娠中にIgA腎症によるネフローゼ症候群を発症し,集学的治療により良好な転帰を得た一例 2025/09/10
|
|
29.
|
原著
|
両腎の多発微小嚢胞からADPKD-DNAJB11と診断した一家系 2025/09/10
|
|
30.
|
原著
|
Attribute-Based Medicine for IgA Nephropathy: Risk Factor Constellations Influence Kidney Prognosis. 2025/08/27
|
|
31.
|
原著
|
Attribute based cross classification analyses from the BRIGHTEN study reveal that therapeutic responsiveness to erythropoiesis stimulating agents predicts cardiorenal prognosis in renal anemia. 2025/07/02
|
|
32.
|
原著
|
ADPKD患者における腎予後に関する性差 属性に基づく医療(ABM)の視点より 2025/06/04
|
|
33.
|
原著
|
ARNIによるSGLT2阻害薬のinitial dip抑制効果の検討 2025/06/04
|
|
34.
|
原著
|
SLE患者におけるヒドロキシクロロキン使用に伴うゼブラボディ/ミエロイドボディ出現の検討 2025/06/04
|
|
35.
|
原著
|
Brevibacterium speciesによるPD腹膜炎の1例 2025/06
|
|
36.
|
原著
|
Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5. 2025/06
|
|
37.
|
原著
|
トシリズマブ投与中のPD患者に発症した急性虫垂炎の1例 2025/06
|
|
38.
|
原著
|
透析前随時血糖値と糖尿病を合併した維持血液透析患者の死亡率の関連 日本透析医学会統計調査の検討 2025/06
|
|
39.
|
原著
|
Overexpression of plasmalemmal vesicle-associated protein-1 in patient with cyanotic nephropathy: a case report. 2025/03
|
|
40.
|
原著
|
常染色体顕性(優性)多発性嚢胞腎におけるSplicing mutationと脳動脈瘤発症の関連性について 2025/03
|
|
41.
|
原著
|
Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease. 2025/01
|
|
42.
|
原著
|
Urinary casts containing crystals in light chain proximal tubulopathy. 2024/11
|
|
43.
|
原著
|
腎生検所見から何を学ぶか(No.67) 急激な腎機能障害,心機能障害を呈しcrystalglobulin-induced nephrologyが疑われた1例 2024/10/25
|
|
44.
|
原著
|
Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP) 2024/10
|
|
45.
|
症例報告
|
30年の長期寛解後に再発したC3腎炎の一例 2024/09/10
|
|
46.
|
症例報告
|
感染後糸球体腎炎(PIGN)を発症した腎移植ドナーの2症例 2024/09/10
|
|
47.
|
症例報告
|
血管炎を呈した薬剤性尿細管間質性腎炎の1例 2024/09/10
|
|
48.
|
症例報告
|
高安動脈炎,腎動脈狭窄によるFSGSに経皮的腎動脈形成術(PTRA)が著効した一例 2024/09/10
|
|
49.
|
症例報告
|
腎生検でIgG-κ産生B細胞性リンパ腫を診断したCrystal storing histiocytosis(CSH)の一例 2024/09/10
|
|
50.
|
症例報告
|
致死的な経過をたどったCrystalglobulin-induced nephropathyの一例 2024/09/10
|
|
51.
|
症例報告
|
尿沈渣が診断に有用であったLight chain proximal tubulopathy(LCPT)の3例 2024/09/10
|
|
52.
|
原著
|
Novel Flow Cytometry Method Detecting Complement C1q Bound to Blood Type A/B IgG Antibody for Preventing Severe Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation. 2024/08/01
|
|
53.
|
原著
|
IgA腎症における属性医療(ABM)～性差,年齢,BMI,CKD-stageの腎予後因子への影響について 2024/06/15
|
|
54.
|
原著
|
常染色体顕性多発性嚢胞腎における脳動脈瘤と脳出血の有病率と特徴 2024/06/15
|
|
55.
|
原著
|
ADPKD患者の脳動脈瘤に関する性差について 2024/06
|
|
56.
|
原著
|
Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD 2024/05/31
|
|
57.
|
症例報告
|
胆管交通性感染肝嚢胞に対して胆管バルーン併用硬化療法で感染制御，瘻孔閉鎖できた一例 2024/05/28
|
|
58.
|
原著
|
Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. 2024/05
|
|
59.
|
総説
|
【日常診療で診るCKD-乗り遅れないための最新情報】CKDの予防医療 腎臓リハビリテーション 2024/05
|
|
60.
|
原著
|
常染色体顕性(優性)多発性嚢胞腎におけるSplicing mutationと脳動脈瘤発症の関連性について 2024/03
|
|
61.
|
原著
|
PLA2R-positive membranous nephropathy in IgG4-related disease 2024/02/23
|
|
62.
|
原著
|
Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2024/02/05
|
|
63.
|
原著
|
Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease 2024/01
|
|
64.
|
原著
|
Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. 2023/11/03
|
|
65.
|
原著
|
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease. 2023/10
|
|
66.
|
原著
|
Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate "diseased" from "normal" 2023/07/13
|
|
67.
|
総説
|
HIF-PH阻害薬の網膜への影響 2023/05
|
|
68.
|
原著
|
機械学習を用いたADPKDにおける脳動脈瘤発症関連因子の検討 2023/05
|
|
69.
|
総説
|
腎性貧血診療における属性(性差,年齢)の影響について 2023/05
|
|
70.
|
総説
|
Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD). 2022/11
|
|
71.
|
原著
|
Machine learning for morbid glomerular hypertrophy. 2022/11
|
|
72.
|
原著
|
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2022/10/27
|
|
73.
|
総説
|
【多発性嚢胞腎（ADPKD)の合併症とその治療】脳動脈瘤 2022/10/25
|
|
74.
|
原著
|
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease. 2022/06
|
|
75.
|
原著
|
Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polystic Kidney Disease 2022/05/20
|
|
76.
|
原著
|
Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining. 2022/04
|
|
77.
|
原著
|
Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study 2022/03/08
|
|
78.
|
原著
|
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease 2022/01/29
|
|
79.
|
原著
|
Germline Mutations for Kidney Volume in ADPKD 2021/12/13
|
|
80.
|
総説
|
ADPKD 3）遺伝子診断：診断と予後 2021/11
|
|
81.
|
原著
|
Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy:Importance of Type ⅣCollagen 2021/10/12
|
|
82.
|
原著
|
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD 2021/07/14
|
|
83.
|
原著
|
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease 2021/07
|
|
84.
|
原著
|
Renal amyloidosis with monotypic IgM lambda deposition 2021/07
|
|
85.
|
原著
|
Renal amyloidosis with monotypic IgM lambda deposition 2021/06/19
|
|
86.
|
原著
|
Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease 2021/05/18
|
|
87.
|
原著
|
Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes 2021/05/01
|
|
88.
|
原著
|
Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease 2021/04/02
|
|
89.
|
原著
|
The origin of urinary mulberry cells in Fabry 2021/04
|
|
90.
|
原著
|
Impact of visceral fat area in patients with chronic kidney desease 2021/02/17
|
|
91.
|
その他
|
【腎疾患領域における難病対策】多発性嚢胞腎における対策 2021/01
|
|
92.
|
原著
|
Everolimus-associated focal segmental glomerulosclerosis in a liver transplant recipient 2020/12/09
|
|
93.
|
原著
|
Cell invasion in glomerular basement membrane: infolding glomerulopathy 2020/12/06
|
|
94.
|
原著
|
Sex Differences in Time-Series Changes in Pseudo-R² Values Regarding Hyperuricemia in Relation to the Kidney Prognosis 2020/11/26
|
|
95.
|
原著
|
Visceral to subcutaneous fat ratio as an indicator of a ≧30％ eGFR decline in chronic kidney disease 2020/11
|
|
96.
|
原著
|
Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan 2020/09/03
|
|
97.
|
原著
|
A standardized protocol for the mulberry cells and mulberry bodies in the urinary sediment of Fabry disease 2020/07/11
|
|
98.
|
原著
|
Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study. 2020/05/07
|
|
99.
|
原著
|
Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease. 2020/04
|
|
100.
|
原著
|
High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study 2020/03/10
|
|
101.
|
原著
|
Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. 2020/02/08
|
|
102.
|
原著
|
Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations. 2020/01/05
|
|
103.
|
原著
|
Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease. 2019/12/09
|
|
104.
|
原著
|
Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance(MGRS) 2019/10/17
|
|
105.
|
原著
|
Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis. 2019/09
|
|
106.
|
原著
|
Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome 2019/08/20
|
|
107.
|
原著
|
A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression. 2019/06
|
|
108.
|
原著
|
Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients 2019/04
|
|
109.
|
原著
|
Low HDL cholesterol as a predictor of chronic kidney disease progression:a cross-classification approach and matched cohort analysis. 2019/03
|
|
110.
|
原著
|
PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion 2019/01
|
|
111.
|
原著
|
Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis:A case report. 2019/01
|
|
112.
|
原著
|
Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/12
|
|
113.
|
原著
|
Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD). 2018/10
|
|
114.
|
原著
|
Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Repuired Surgical Treatment 2018/08
|
|
115.
|
原著
|
A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement. 2018/05
|
|
116.
|
原著
|
Large Renel Corpuscle:Clinical Significance of Evaluation of the Largest Renal Corpuscle in Kidney Biopsy Specimens. 2018/05
|
|
117.
|
原著
|
New Insights into Cystic Kidney Diseases. 2018/05
|
|
118.
|
総説
|
【腎硬化症-今日の視点から】良性腎硬化症 高尿酸血症と腎硬化症 2018/05
|
|
119.
|
原著
|
Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/03
|
|
120.
|
原著
|
Serum Soluble(Pro)Renin Receptor Level is Increased in Association with Impaired Renal Function in Patients with Autosomal Dominant Polycystic Kedney Disease 2018/02
|
|
121.
|
原著
|
A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement 2018/01
|
|
122.
|
総説
|
多発性嚢胞腎治療の国際比較 2018/01
|
|
123.
|
原著
|
Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease. 2017/11
|
|
124.
|
原著
|
Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2017/06
|
|
125.
|
総説
|
【おさらい腎疾患-明日から役立つアプローチの基本】尿細管間質疾患 常染色体優性多発性嚢胞腎 2017/02
|
|
126.
|
原著
|
Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis:Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2017/01
|
|
127.
|
総説
|
多発性嚢胞腎の診断・治療の進歩 2017
|
|
128.
|
原著
|
Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis:Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2016/10
|
|
129.
|
原著
|
常染色体優性多発性嚢胞腎におけるV2受容体拮抗薬（トルバプタン） 2016/08
|
|
130.
|
原著
|
常染色対優性多発性嚢胞腎におけるV2受容体拮抗薬（トルバプタン） 2016/08
|
|
131.
|
原著
|
Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease. 2016/07
|
|
132.
|
原著
|
蛋白尿の鑑別診断（成人） 2016/07
|
|
133.
|
症例報告
|
IgA腎症に対する扁摘パルス・パルス単独療法におけるプロトコールの違いが予後に与える影響 2016/05
|
|
134.
|
総説
|
多発性嚢胞腎 新たな観点から見据えて 2016/05
|
|
135.
|
原著
|
Relationship between variations in time-dependent response to erythropoiesis-stimulating agents and mortality in hemodialysis patients: a single-center study 2016/02
|
|
136.
|
原著
|
ANCA関連血管炎による間質性肺炎増悪に対しリツキシマブ投与を行った透析例 2016/01
|
|
137.
|
原著
|
ANCA関連血管炎による間質性肺炎憎悪に対しリツキシマブ投与を行った透析例 2016/01
|
|
138.
|
症例報告
|
ＡＮＣＡ関連血管炎による間質性肺炎憎悪に対しリツキシマブ投与を行った透析例 2016/01
|
|
139.
|
原著
|
Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro. 2016
|
|
140.
|
原著
|
Relationship between anaemia management at haemodialysis initiation and patient prognosis. 2015/12
|
|
141.
|
原著
|
Relationship between anemia management at hemodialysis initiation and patient prognosis. 2015/10
|
|
142.
|
原著
|
High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. 2015/08
|
|
143.
|
総説
|
【肥満に関連する病態と腎障害】メタボリックシンドロームと腎障害 2015/04
|
|
144.
|
総説
|
ＡＤＰＫＤでの降圧療法 2015/02
|
|
145.
|
原著
|
Associations between the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index of maintenance hemodialysis patients and increased mortality 2015/01
|
|
146.
|
原著
|
Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. 2014/12
|
|
147.
|
原著
|
Serum Hepcidin Levels and Reticulocyte Hemoglobin
Concentrations as Indicators of the Iron Status of Peritoneal
Dialysis Patients 2012/09
|
|
148.
|
原著
|
Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters 2012/02
|
|
149.
|
原著
|
Maximal glomeular diameter as a 10-year prognostic indicator for IgA nephropathy 2011
|
|
5件表示
|
|
全件表示(149件)
|
